ARTICLE | Company News
Roche submits Pegasys BLA
May 22, 2000 7:00 AM UTC
Hoffmann-La Roche submitted a BLA to the FDA for its Pegasys peginterferon alfa-2a to treat chronic hepatitis C infection in cirrhotic and non-cirrhotic patients with compensated liver disease. Pegasy...